IL197701A0 - Micellar nanoparticles of chemical substances - Google Patents

Micellar nanoparticles of chemical substances

Info

Publication number
IL197701A0
IL197701A0 IL197701A IL19770109A IL197701A0 IL 197701 A0 IL197701 A0 IL 197701A0 IL 197701 A IL197701 A IL 197701A IL 19770109 A IL19770109 A IL 19770109A IL 197701 A0 IL197701 A0 IL 197701A0
Authority
IL
Israel
Prior art keywords
chemical substances
micellar nanoparticles
micellar
nanoparticles
substances
Prior art date
Application number
IL197701A
Other versions
IL197701A (en
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of IL197701A0 publication Critical patent/IL197701A0/en
Publication of IL197701A publication Critical patent/IL197701A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
IL197701A 2006-10-20 2009-03-19 Solid composition comprising nanosized micelles and a process for preparing them IL197701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85302306P 2006-10-20 2006-10-20
EP06122648 2006-10-20
PCT/EP2007/061194 WO2008046905A1 (en) 2006-10-20 2007-10-19 Micellar nanoparticles of chemical substances

Publications (2)

Publication Number Publication Date
IL197701A0 true IL197701A0 (en) 2009-12-24
IL197701A IL197701A (en) 2014-12-31

Family

ID=38661928

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197701A IL197701A (en) 2006-10-20 2009-03-19 Solid composition comprising nanosized micelles and a process for preparing them

Country Status (9)

Country Link
EP (1) EP2083799A1 (en)
JP (1) JP5439182B2 (en)
KR (1) KR101434334B1 (en)
AU (1) AU2007312233B2 (en)
CA (1) CA2666587C (en)
EA (1) EA026213B1 (en)
IL (1) IL197701A (en)
NO (1) NO20091975L (en)
WO (1) WO2008046905A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR071375A1 (en) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY, PREPARATION AND PRODUCT PROCESS
KR20110056516A (en) 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
AR075180A1 (en) * 2009-01-29 2011-03-16 Novartis Ag SOLID ORAL FORMULATIONS OF A PYRIDOID-PYRIMIDINONE
EP2841090A1 (en) * 2012-04-24 2015-03-04 Amylin Pharmaceuticals, LLC Site-specific enzymatic modification of exendins and analogs thereof
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
FR3014317B1 (en) * 2013-12-11 2016-04-22 Patrice Binay NOVEL PROCESS FOR THE PRODUCTION OF TRANSMUCAL PHARMACEUTICAL FORMULATIONS AND FORMATIONS THUS OBTAINED
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
WO2020107119A1 (en) * 2018-11-30 2020-06-04 Canopy Growth Corporation Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use
EP4005561A4 (en) * 2019-07-25 2022-12-07 Beijing Shenogen Pharma Group Ltd. Nano-micelle preparation of icaritin and preparation method therefor and application thereof
CN112915121A (en) 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 Cannabinoid nano micelle preparation and preparation method thereof
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
AU2022315590A1 (en) * 2021-07-22 2024-01-18 Nicoventures Trading Limited Composition comprising a constituent, derivative or extract of cannabis
CA3225822A1 (en) * 2021-07-22 2023-01-26 Steven Alderman Compositions comprising constituents, derivatives or extracts of cannabis
WO2023002197A1 (en) * 2021-07-22 2023-01-26 Nicoventures Trading Limited Compositions comprising a constituent, derivative or extract of cannabis
IL309703A (en) * 2021-07-22 2024-02-01 Nicoventures Trading Ltd Constituent, derivative or extract of cannabis in a water soluble matrix

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
FR2804604B1 (en) * 2000-02-09 2005-05-27 Sanofi Synthelabo USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF USEFUL DRUGS TO FACILITATE THE STOPPAGE OF TOBACCO CONSUMPTION
MXPA03009439A (en) * 2001-09-21 2004-02-12 Solvay Pharm Bv 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity.
CA2456606C (en) * 2001-09-21 2010-01-26 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
GB0305941D0 (en) * 2003-03-14 2003-04-23 Camurus Ab Composition
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
JP4994039B2 (en) * 2003-11-26 2012-08-08 スパーナス ファーマシューティカルズ インコーポレイテッド Micellar system useful for delivery of lipophilic or hydrophobic compounds
WO2005053727A2 (en) * 2003-11-29 2005-06-16 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents
KR20060123493A (en) * 2003-12-23 2006-12-01 알자 코포레이션 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
TW200529890A (en) * 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
CA2585175A1 (en) * 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
ES2545589T3 (en) * 2005-04-08 2015-09-14 Abbott Laboratories Oral pharmaceutical formulations comprising salts of fenofibric acid
JP2008536929A (en) * 2005-04-18 2008-09-11 ルビコン・リサーチ・ピーヴィーティー・エルティーディー Bio-enhancing composition

Also Published As

Publication number Publication date
CA2666587A1 (en) 2008-04-24
CA2666587C (en) 2015-12-22
JP5439182B2 (en) 2014-03-12
EA200900572A1 (en) 2009-10-30
WO2008046905A1 (en) 2008-04-24
AU2007312233A1 (en) 2008-04-24
EA026213B1 (en) 2017-03-31
IL197701A (en) 2014-12-31
KR20090077074A (en) 2009-07-14
NO20091975L (en) 2009-07-09
KR101434334B1 (en) 2014-08-28
EP2083799A1 (en) 2009-08-05
AU2007312233B2 (en) 2012-09-20
JP2010506886A (en) 2010-03-04

Similar Documents

Publication Publication Date Title
IL197701A0 (en) Micellar nanoparticles of chemical substances
EP1984376A4 (en) Chemical compounds
EP2059480A4 (en) Methods of forming nanoparticles
EP2057987A4 (en) Pharmaceutical composition containing statin-encapsulated nanoparticle
GB0613518D0 (en) Chemical compounds
EP2081603A4 (en) Fluorescent chemical sensor
GB0611507D0 (en) Chemical compounds
EP2320910A4 (en) Chemical compounds and uses
GB0611506D0 (en) Chemical compounds
PL1816116T6 (en) Chemical compositions and methods of making them
GB0623388D0 (en) Chemical compounds
EP2349266A4 (en) Sulfonamide containing compounds and uses thereof
GB0611552D0 (en) Chemical compounds
EP2029000A4 (en) Assessment of functional status
HK1199829A1 (en) Micellar nanoparticles of chemical substances
GB0625198D0 (en) Chemical compounds
GB0601215D0 (en) Chemical compounds
GB0613284D0 (en) Detection of substances
GB0623357D0 (en) Chemical compounds
GB0615670D0 (en) Chemical compounds
GB0614552D0 (en) Chemical Compounds
PL2124880T3 (en) Fluorescent nanoparticles
GB0625371D0 (en) Chemical compounds
GB0619677D0 (en) Destruction of chemical substances
GB0624145D0 (en) Chemical substance

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed